Trials / Completed
CompletedNCT06419543
Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy
Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy: Incidence, Characters and Its Impact on Prognostic Outcomes-- a Randomized, Controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 333 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Not accepted
Summary
Exploring the effect of remimazolam dose on paradoxical reactions in pediatric painless gastrointestinal endoscopy.
Detailed description
Exploring the effect of remimazolam dose on paradoxical reactions and sedation in pediatric painless gastrointestinal endoscopy, observing the performance and duration of paradoxical reactions, and analyze the factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | Observe the incidence of paradoxical reactions after the first induction. |
Timeline
- Start date
- 2024-05-20
- Primary completion
- 2024-10-01
- Completion
- 2024-10-01
- First posted
- 2024-05-17
- Last updated
- 2024-10-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06419543. Inclusion in this directory is not an endorsement.